These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Duchenne's muscular dystrophy and malignant hyperthermia: another warning. Rosenberg H; Heiman-Patterson T Anesthesiology; 1983 Oct; 59(4):362. PubMed ID: 6614550 [No Abstract] [Full Text] [Related]
9. Duchenne muscular dystrophy and malignant hyperthermia--two case reports. Wang JM; Stanley TH Can Anaesth Soc J; 1986 Jul; 33(4):492-7. PubMed ID: 3742323 [TBL] [Abstract][Full Text] [Related]
10. Malignant hyperthermia susceptibility in patients with Duchenne's muscular dystrophy. Peluso A; Bianchini A Can J Anaesth; 1992 Dec; 39(10):1117-8. PubMed ID: 1464140 [No Abstract] [Full Text] [Related]
11. Suspected malignant hyperthermia in a child with laminin alpha2 (merosin) deficiency in the absence of a triggering agent. Shukry M; Guruli ZV; Ramadhyani U Paediatr Anaesth; 2006 Apr; 16(4):462-5. PubMed ID: 16618304 [TBL] [Abstract][Full Text] [Related]
12. [Anesthesia in patients with Duchenne muscular dystrophy]. Saint-Maurice C; Egu JF; Gaudiche O; Loose JP; Murat I Ann Fr Anesth Reanim; 1989; 8(5):457-68. PubMed ID: 2697158 [No Abstract] [Full Text] [Related]
13. Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report. Free CW; Jaimon MP N Z Med J; 1978 Dec; 88(626):493-4. PubMed ID: 283330 [TBL] [Abstract][Full Text] [Related]
17. Prophylactic use of dantrolene associated with prolonged postanesthetic recumbency in a horse. Valverde A; Boyd CJ; Dyson DH; Pascoe PJ J Am Vet Med Assoc; 1990 Oct; 197(8):1051-3. PubMed ID: 2243040 [TBL] [Abstract][Full Text] [Related]
19. [Postoperative respiratory depression thought to be due to oral dantrolene pretreatment in a malignant hyperthermia-susceptible patient]. Hara Y; Kato A; Horikawa H; Kato Y; Ichiyanagi K Masui; 1988 Apr; 37(4):483-7. PubMed ID: 3398231 [No Abstract] [Full Text] [Related]